Use of autoshaping with non-delayed and delayed reinforcement for studying effects upon acquisition and consolidation of information

Methods of Behavior Analysis in Neuroscience

Volumn , Issue , 2000, Pages 231-267

  Sparber, Sheldon B ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85057683051     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (65)

1. Brown, P. L. and Jenkins, H. M., Auto-shaping of the pigeon’s key-peck. Journal of Experimental Analysis of Behavior, 11, 1, 1968.
2. Terrace, H. S., Introduction: Autoshaping and two-factor learning theory. In: Autoshaping and Conditioning Theory, Locurto, C. M., Terrace, H. S., and Gibbon, J., Eds., Academic Press, New York, 15, 1981.
3. Locurto, C. M., Terrace, H. S., and Gibbon, J., Eds., Autoshaping and Conditioning Theory, Academic Press, New York, 1981.
4. Cunningham, C. L., Ostroff, R. L., and Harris, D. F., Thermoregulation and performance of heat-reinforced autoshaped key pecking in chicks. Behavior and Neural Biology, 51, 54, 1989.
5. Carroll, M. E. and Lac, S. T., Autoshaping i.v. cocaine self-administration in rats: effects of nondrug alternative reinforcers on acquisition. Psychopharmacology, 110, 5, 1993.
6. Janak, P. H., Rodriguez, W. A., and Martinez, Jr., J. L., Cocaine impairs acquisition of an autoshaped lever-touch response. Psychopharmacology, 130, 213, 1997.
7. Aubert, A., Vega, C., Dantzer, R., and Goodall, G., Pyrogens specifically disrupt the acquisition of a task involving cognitive processing in the rat. Brain Behavior and Immunity, 9, 148, 1995.
8. Sparber, S. B., Is prenatal induction of tyrosine hydroxylase associated with postnatal behavioral changes? In: Maturation of Neurotransmission. Vernadakis, A., Giacobini E., and Filagamo, G., Eds., S. Karger, Basel, 200, 1978.
9. Lydiard, R. B. and Sparber, S. B., Postnatal behavioral alterations resulting from prenatal administration of dl-alpha-methylparatyrosine. Developmental Psychobiology, 10, 305, 1977.
10. Sparber, S. B., Postnatal behavioral effects of in utero exposure to drugs which modify catecholamines and/or serotonin. In: Drugs and the Developing Brain, Vernadakis, A. and Weiner, N., Eds., Plenum Press, New York, 81, 1974.
11. Bollweg, G. and Sparber, S., Ritanserin blocks DOI-altered embryonic motility and posthatch learning in the developing chicken. Pharmacology Biochemistry and Behavior.55, 397, 1996.
12. Goldstein, L. H. and Oakley, D. A., Autoshaping in microencephalic rats. Behavioral Neuroscience, 103, 566, 1989.
13. Poplawsky, A. and Phillips, C. L., Autoshaping a leverpress in rats with lateral, medial, or complete septal lesions. Behavioral and Neural Biology, 45, 319, 1986.
14. van Haaren, F., van Zÿderveld, G., van Hest, A., de Bruin, J. P., van Eden, C. G., and van de Poll, N. E., Acquisition of conditional associations and operant delayed spatial response alternation: effects of lesions in the medial prefrontal cortex. Behavioral Neuroscience, 102, 481, 1988.
15. Sparber, S. B., Effects of drugs on the biochemical and behavioral responses of developing organisms. Federation Proceedings, 31, 74, 1972.
16. Rosenthal, E. and Sparber, S. B., Methylmercury dicyandiamide: Retardation of detour learning in chicks hatched from injected eggs. Life Sciences, 11, 883, 1972.
17. Spyker, J. M., Sparber, S. B., and Goldberg, A. M., Subtle consequences of methylmercury exposure: Behavioral deviations in offspring of treated mothers. Science, 177, 621, 1972.
18. Hughes, J. A. and Sparber, S. B., d-Amphetamine unmasks postnatal consequences of exposure to methylmercury in utero: Methods for studying behavioral teratogenesis. Pharmacology Biochemistry and Behavior, 8, 365, 1978.
19. Reuhl, K., Delayed expression of neurotoxicity: The problem of silent damage. Neurotoxicology, 12, 341, 1991.
20. Cohen, C. A., Messing, R. B., and Sparber, S. B., Selective learning impairment of delayed reinforcement autoshaped behaviors caused by low doses of trimethyltin. Psychopharmacology, 93, 301, 1987.
21. Lubow, R. E. and Moore, A. U., Latent inhibition: effects of non-reinforced preexposure to the conditioned stimulus. Journal of Comparative and Physiological Psychology, 52, 415, 1959.
22. Weiner, I. and Feldon, J., The switching model of latent inhibition: an update of neural substrates. Behavioral Brain Research, 88, 11, 1997.
23. Collier, T. J., Quirk, G. J., and Routtenberg, A., Separable roles of hippocampal granule cells in forgetting and pyramidal cells in remembering spatial information. Brain Research, 409, 316, 1987.
24. Huang, M., Messing, R. B., and Sparber, S. B., Learning enhancement and behavioral arousal induced by yohimbine. Life Sciences, 41, 1083, 1987.
25. Messing, R. B. and Sparber, S. B., Greater task difficulty amplifies the facilitatory effect of des-glycinamide arginine vasopressin on appetitively motivated learning. Behavioral Neuroscience, 99, 1114, 1985.
26. Messing, R. B., Kleven, M. S., and Sparber, S. B., Delaying reinforcement in an autoshaping task generates adjunctive and superstitious behaviors. Behavioural Processes, 13, 327, 1986.
27. Messing, R. B. and Sparber, S. B., Des-gly-vasopressin improves acquisition and slows extinction of autoshaped behavior. European Journal of Pharmacology, 89, 43, 1983.
28. Ross, W. D., Emmett, E. A., Steiner, J., and Tureen, T., Neurotoxic effects of occupational exposure to organotins. American Journal of Psychology, 138, 1092, 1981.
29. Tilson, H. A. and Sparber, S. B., Eds., Neurotoxicants and Neurobiological Function: Effects of Organoheavy Metals. John Wiley & Sons, New York, 1987.
30. Cohn, J. and MacPhail, R. C., Acute trimethyltin exposure produces nonspecific effects on learning in rats working under a multiple repeated acquisition and performance schedule. Neurotoxicology and Teratology, 18, 99, 1996.
31. Gerbec, E. N., Messing, R. B., and Sparber, S. B., Parallel changes in operant behavioral adaptation and hippocampal corticosterone binding in rats treated with trimethlytin. Brain Research, 460, 346, 1988.
32. Messing, R. B., Bollweg, G., Chen, Q., and Sparber, S. B., Dose-specific effects of trimethyltin poisoning on learning and hippocampal corticosterone binding. Neurotoxicology, 9, 491, 1988.
33. Sparber, S. B., Bollweg, G. L., and Messing, R. B., Food deprivation enhances both autoshaping and autoshaping impairment by a latent inhibition procedure. Behavioral Processes, 23, 59, 1991.
34. Solomon, P. R., Neural and behavioral mechanism involved in learning to ignore irrelevant stimuli. In: Classical Conditioning, Gormezano, I., Prokasy, W. F., and Thompson, R. F., Eds., Lawrence Erlbaum Assoc., Hillsdale, NJ, 117, 1987.
35. Swartzwelder, H. S., Hepler, H. S. J., Holahan, W., King, S. E., Leverenz, H. A., Miller, P. A., and Myers, R. D., Impaired maze performance in the rat caused by trimethyltin treatment: Problem solving deficits and perseveration. Neurobehavioral Toxicology and Teratology, 4, 169, 1982.
36. Coveney, J. R. and Sparber, S. B., Phencylidine retards autoshaping at a dose which does not suppress the required response. Pharmacology Biochemistry and Behavior, 16, 937, 1982.
37. Sparber, S. B., O’Callaghan, J. P., and Berra, B., Ganglioside treatment partially counteracts neurotoxic effects of trimethyltin but may itself cause neurotoxicity in rats: Experimental results and a critical review. Neurotoxicology, 13, 679, 1992.
38. Bollweg, G., Balaban, C. D., Berra, B., and Sparber, S. B., Potential efficacy and toxicity of GM1 ganglioside against trimethyltin-induced brain lesions in rats: Comparison with protracted food restriction. Neurotoxicology, 16, 239, 1995.
39. Deutsch, J., Higher nervous function: The psychological basis of memory. Annual Review of Physiology, 24, 259, 1962.
40. Deutsch, J., The cholinergic synapse and the site of memory. Science, 174, 788, 1971.
41. Davis, K. L., Hollister, L. E., Overall, J., Johnson, A., and Train, K., Physostigmine: Effects on cognition and effects in normal subjects. Psychopharmacology, 51, 23, 1976.
42. Davis, K. L., Mohs, R. C., Tinklenberg, J. R., Pfefferbaum, A., Hollister, L. E., and Kopell, B. S., Physostigmine: improvement of long-term memory processes in normal humans. Science, 201, 272, 1978.
43. Davies, P. and Maloney, A. J. F., Selective loss of central cholinergic neurons in Alzheimer’s Disease. Lancet, 2, 1403, 1976.
44. Roberts, G. W., Crow, T. J., and Polak, J. M., Location of neuronal tangles in somatostatin neurones in Alzheimer’s Disease. Nature, 314, 92, 1985.
45. Yamamoto T. and Hirano A., Nucleus Raphe Dorsalis in Alzheimer’s Disease: Neurofibrillary tangles and loss of large neurons. Annals of Neurology, 17, 573, 1984.
46. Mohs, R. C., Davis, B. M., Johns, C. A., Mathé, A. A., Greenwald, B. S., Horvath, T. B., and Davis, K. L., Oral physostigmine treatment of patients with Alzheimer’s Disease. American Journal of Psychiatry, 142, 28, 1985.
47. Muramoto, O., Sugishita, M., and Ando, K., Cholinergic system and constructural praxis: a further study of physostigmine in Alzheimer’s Disease. Journal of Neurology, Neurosurgery, and Psychiatry, 47, 485, 1984.
48. Caltagirone, C., Gainotti, G., and Masullo, C., Oral administration of chronic physostigmine does not improve cognitive or mnesic performances in Alzheimer’s Presenile Dementia. International Journal of Neuroscience, 16, 247, 1982.
49. Jenike, M. A., Albert, M. S., Heller, H., Gunther, J., and Goff, D., Oral physostigmine treatment for patients with presenile and senile dementia of the Alzheimer’s type: a double-blind placebo-controlled trial. Journal of Clinical Psychiatry, 51, 3-, 1990.
50. Jotkowitz, S., Lack of clinical efficacy of chronic oral physostigmine in Alzheimer’s Disease. Annals of Neurology, 14, 690, 1983.
51. Peters, B. H. and Levin, H. S., Effects of physostigmine and lecithin on memory in Alzheimer’s Disease. Annals of Neurology, 6, 219, 1979.
52. Schwartz, A. S. and Kohlstaedt, E. V., Physostigmine effects in Alzheimer’s Disease: relationship to dementia severity. Life Sciences, 38, 1021, 1986.
53. Cox, T. and Tye, N., Effects of physostigmine on the acquisition of a position discrimination in rats. Neuropharmacology, 12, 477, 1982.
54. Leaf, R. C. and Muller, S. A., Effects of scopolamine on operant avoidance acquisition and retention. Psychopharmacologia, 9, 101, 1966.
55. Stratton, L. D. and Petrinovich, L., Post trial injections of an anticholinesterase drug and maze learning in two strains of rats. Psychopharmacologia, 5, 47, 1963.
56. Rech, R. H., Effects of cholinergic drugs on poor performance of rats in a shutttle box. Psychopharmacologia, 12, 371, 1968.
57. Parker, L. A., Hutchinson, S., and Riley, A. L., Conditioned flavor aversions: A toxicity test of the anticholinesterase agent, physostigmine. Neurobehavioral Toxicology and Teratology, 4, 93, 1982.
58. Romano, J. A., King, J. M., and Penetar, D. M., A comparison of physostigmine and soman using taste aversion and nociception. Neurobehavioral Toxicology and Teratology, 7, 243, 1985.
59. Locke, K. W., Gorney, B., Cornfeldt, M., and Fielding, S., Characterization of the discriminative stimulus effects of physostigmine in the rat. Journal of Pharmacolology and Experimental Therapeutics, 250, 241, 1989.
60. Tang A. H. and Franklin S. R., Discriminative stimulus properties of physostigmine in rats. European Journal of Pharmacology, 153, 97, 1988.
61. Sivam, S. P., Hoskins, B., and Ho, I. K., An assessment of comparative acute toxicity of diisopropylflorophosphate, tabun, sarin, and soman in relation to cholinergic and GABAergic enzyme activities in rats. Fundamental and Applied Toxicology, 4, 531, 1984.
62. Sparber, S. B. and Tilson H. A., Environmental influences upon drug-induced suppression of operant behavior. The Journal of Pharmacology and Experimental Therapeutics, 179, 1, 1971.
63. Sparber, S. B., Tilson, H. A., and Peterson, D. W., Environmental influences upon morphine or d-amphetamine induced suppression of operant behavior. Pharmacology, Biochemistry and Behavior, 1, 133, 1973.
64. Jarbe, T. C. U., Laaksonen, T., and Svensson, R., Influence of exteroceptive contextual conditions upon internal drug stimulus control. Psychopharmacology, 80, 31, 1980.
65. Maayani, S., Egozi, Y., Pinchasi, I., and Sokolovsky, M., On the interaction of drugs with the cholinergic nervous system. VI. Tolerance to physostigmine in mice. Psychopharmacology, 55, 43, 1977.